Cue dependency of nicotine self-administration and smoking

https://doi.org/10.1016/S0091-3057(01)00676-1Get rights and content

Abstract

A paradox exists regarding the reinforcing properties of nicotine. The abuse liability associated with smoking equals or exceeds that of other addictive drugs, yet the euphoric, reinforcing and other psychological effects of nicotine, compared to these other drugs, are more subtle, are manifest under more restricted conditions, and do not readily predict the difficulty most smokers experience in achieving abstinence. One possible resolution to this apparent inconsistency is that environmental cues associated with drug delivery become conditioned reinforcers and take on powerful incentive properties that are critically important for sustaining smoking in humans and nicotine self-administration in animals. We tested this hypothesis by using a widely employed self-administration paradigm in which rats press a lever at high rates for 1 h/day to obtain intravenous infusions of nicotine that are paired with two types of visual stimuli: a chamber light that when turned on signals drug availability and a 1-s cue light that signals drug delivery. We show that these visual cues are at least as important as nicotine in sustaining a high rate of responding once self-administration has been established, in the degree to which withdrawing nicotine extinguishes the behavior, and in the reinstatement of lever pressing after extinction. Additional studies demonstrated that the importance of these cues was manifest under both fixed ratio and progressive ratio (PR) schedules of reinforcement. The possibility that nicotine-paired cues are as important as nicotine in smoking behavior should refocus our attention on the psychology and neurobiology of conditioned reinforcers in order to stimulate the development of more effective treatment programs for smoking cessation.

Introduction

Tobacco smoking is the most important preventable cause of death in developed countries and is rapidly becoming a significant health problem in developing countries. Although the prevalence of smoking has gradually declined among adults (but not teens) in developed countries, worldwide consumption of tobacco is still rising. It is predicted that about 3 million smokers worldwide die annually from smoking, and that the rapid increase in smoking in developing countries (Peto et al., 1996) will cause this toll to rise to about 10 million annually by the year 2030. Several hundred million adults who are current smokers are expected to die from smoking (Peto et al., 1996). Although the harmful health effects from smoking are widely known, only an estimated 3% of smokers successfully quit each year, less than 10% of those who attempt smoking abstinence (Shiffman et al., 1998).

With these risks associated with smoking, it is relevant to question why people smoke, why they develop an addiction to smoking, and why many of them cannot quit? The widely accepted answers are that they smoke because smoking is a very efficient way of rapidly delivering nicotine to the brain, nicotine has powerful reinforcing effects like cocaine, heroin and other drugs of abuse, and like those other drugs, chronic usage leads to dependence and addiction Benowitz, 1996, Stolerman and Shoaib, 1991. Based on the very reasonable assumption that people smoke tobacco primarily to obtain nicotine, much animal research has focused on the neurophysiological consequences of nicotine and pharmacological treatments that can reduce its effects Balfour et al., 2000, Di Chiara, 2000. In the human clinical literature, a similar emphasis has been placed on the development of strategies for reducing cigarette smoking, such as nicotine gum or patch, that are directed at the actions of nicotine Benowitz, 1993, Rose and Corrigall, 1997.

However, a paradox exists in both the animal and human literature that is not adequately addressed by these approaches. The abuse liability, frequency of consumption, and rate of relapse associated with smoking are at least equal to other addictive drugs such as stimulants or opiates (Anthony et al., 1994). In contrast, the euphoric, reinforcing and other psychological effects of nicotine, compared to other drugs, are more subtle, are manifested under more restricted conditions, and do not readily predict the difficulty most smokers experience in achieving abstinence Goldberg et al., 1981, Rose and Corrigall, 1997, Rose and Levin, 1991. The limited success rates of smoking cessation treatments that are directed at nicotine's pharmacological actions (Balfour and Fagerstrom, 1996) also suggest that nonnicotine factors may also be involved in maintaining smoking behavior and fostering relapse.

One possible resolution to this paradox is that in addition to its intrinsic reinforcing properties, nicotine is particularly effective in establishing or magnifying the incentive properties and reinforcing effects of associated, nonpharmacological stimuli, such as the predictive visual and/or auditory cues typically found in animal self-administration paradigms, or the taste and smell of tobacco smoke for smokers Balfour et al., 2000, Di Chiara, 2000, Goldberg and Henningfield, 1988, Goldberg et al., 1981, Perkins et al., 2001a, Rose and Corrigall, 1997, Rose and Levin, 1991. Smoking may be a more effective way of establishing these stimuli as conditioned reinforcers, compared to other routes of nicotine administration (e.g., smokeless tobacco) that are likely to be associated with fewer salient environmental cues and, therefore fewer discrete pairings of cues with nicotine delivery (i.e., inhaled versus absorption through the mucous membrane).

In the present paper, we will briefly review the results of human and animal research in support of the hypotheses that: (a) nicotine is the major psychoactive factor in tobacco that drives smoking behavior; (b) the primary (unconditioned) reinforcing effects of nicotine, when considered in isolation, are inadequate to explain the tenacity of smoking behavior or the only modest success of nicotine-based treatment strategies; and (c) environmental stimuli associated with exposure to nicotine play a critical role in maintaining drug-taking behavior and in promoting relapse. We will then present new studies from our laboratory that test the hypothesis regarding the importance of drug-related environmental cues in an animal model of nicotine reinforcement. Our results indicate that the high rate of nicotine self-administration exhibited by rats, which has been reported by several laboratories including our own, is heavily dependent on environmental cues associated with the drug.

Section snippets

Nicotine as the major factor driving smoking behavior

Nicotine is the primary constituent of tobacco that reinforces smoking behavior (Stolerman and Jarvis, 1995). The few attempts made by tobacco companies to market nonnicotine tobacco cigarettes have generally failed (Jaffe, 1990), indicating that nicotine is necessary (but perhaps not always sufficient) in promoting cigarette smoking behavior in most individuals. Self-administration of nicotine in isolation from tobacco smoke has been demonstrated in smokers not trying to quit, using

The need to postulate a role for nonpharmacological stimuli in nicotine self-administration and smoking

As noted, nicotine is the principal pharmacological ingredient in cigarette smoke driving smoking behavior, and it can serve as a reinforcer for self-administration behavior in animals. However, other evidence makes it difficult to explain several key features of smoking and nicotine self-administration by simply invoking the primary (unconditioned) reinforcing effects of nicotine. These features include the relative insensitivity of smoking and nicotine self-administration to dose, the

The importance of associative cues in smoking

We Donny et al., 1999b, Donny et al., 2000b and others Balfour et al., 2000, Di Chiara, 2000, Rose and Corrigall, 1997 have suggested that environmental cues associated with nicotine delivery are capable of maintaining nicotine-seeking behavior even in the absence of a pharmacological effect of the drug. This suggestion is consistent with a large body of literature demonstrating the importance of conditioned cues in self-administration of other drugs of abuse Arroyo et al., 1998, DeWitt and

Evidence that associative cues influence nicotine self-administration in animals

Most studies of nicotine self-administration in animals have employed paradigms in which nicotine infusions are systematically paired with one or more nonpharmacological stimuli Ator and Griffiths, 1993, Bardo et al., 1999, Corrigall and Coen, 1989, Donny et al., 1995, Goldberg et al., 1981, Goldberg et al., 1983, Goldberg et al., 1989, Lynch and Carroll, 1999, Shoaib et al., 1997, Slifer and Balster, 1985, Stolerman et al., 1999, Tessari et al., 1995, Valentine et al., 1997, Watkins et al.,

Conclusions and significance

The present results strongly indicate that, in addition to its intrinsic reinforcing properties, nicotine promotes self-administration behavior by establishing or magnifying the reinforcing effects of associated, nonpharmacological stimuli, such as the visual and/or auditory cues typically found in animal self-administration paradigms. In the absence of nicotine stimulation, these cues are capable of maintaining significant levels of operant behavior for extended periods of time and of

Acknowledgements

This work was supported by National Institute on Drug Abuse research grants, DA-10464 and DA-12655. “Principles of laboratory animal care” (NIH No. 85-23, revised 1985) were followed throughout all experiments. This research was approved by the University of Pittsburgh Institutional Animal Care and Use Committee, Assurance Number A3187-01.

References (149)

  • EC Donny et al.

    Differential effects of response-contingent and response-independent nicotine in rats

    Eur J Pharmacol

    (2000)
  • SR Goldberg et al.

    Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection

    Pharmacol, Biochem Behav

    (1988)
  • SR Goldberg et al.

    Control of behavior by intravenous nicotine injections in laboratory animals

    Pharmacol, Biochem Behav

    (1983)
  • JW Grimm et al.

    Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of relapse

    Neuropsychopharmacology

    (2000)
  • J Gross et al.

    Nicotine-containing versus de-nicotinized cigarettes: effects on craving and withdrawal

    Pharmacol, Biochem Behav

    (1997)
  • RP Hammer et al.

    Neural mechanisms of tolerance to the effects of cocaine

    Behav Brain Res

    (1997)
  • DK Hatsukami et al.

    Smoking topography and nicotine blood levels

    Addict Behav

    (1988)
  • JE Henningfield et al.

    Control of behavior by intravenous nicotine injections in human subjects

    Pharmacol, Biochem Behav

    (1983)
  • JE Henningfield et al.

    Higher levels of nicotine in arterial than in venous blood after cigarette smoking

    Drug Alcohol Depend

    (1993)
  • GF Koob et al.

    Neuroscience of addiction

    Neuron

    (1998)
  • E Levin et al.

    Development of a citric acid aerosol as a smoking cessation aid

    Drug Alcohol Depend

    (1990)
  • DH Malin et al.

    Rodent model of nicotine abstinence syndrome

    Pharmacol, Biochem Behav

    (1992)
  • MC Martellotta et al.

    Isradipine inhibits nicotine intravenous self-administration in drug-naive mice

    Pharmacol, Biochem Behav

    (1995)
  • M Moolten et al.

    Oral self-administration of ethanol and not experimenter-administered ethanol facilitates rewarding electrical brain stimulation

    Alcohol

    (1990)
  • G Panagis

    Nicotine injections into the ventral tegmental area increase locomotion and fos-like immunoreactivity in the nucleas accumbens of the rat

    Brain Res

    (1996)
  • KA Perkins et al.

    Nicotine preference in smokers as a function of smoking abstinence

    Pharmacol, Biochem Behav

    (1996)
  • M Alkondon et al.

    Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: I. Pharmacological and functional evidence for distinct structural subtypes

    J Pharmacol Exp Ther

    (1993)
  • JC Anthony et al.

    Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the national comorbidity survey

    Exp Clin Psychopharmacol

    (1994)
  • JM Arnold et al.

    A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement

    Pharmacol, Biochem Behav

    (1997)
  • M Arroyo et al.

    Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: effects of conditioned cues and continuous access to cocaine

    Psychopharmacology (Berlin)

    (1998)
  • N Ator et al.

    Differential sensitivity to midazolam discriminative-stimulus effects following self-administered versus response-independent midazolam

    Psychopharmacology (Berlin)

    (1993)
  • MT Bardo et al.

    Nornicotine is self-administered intravenously by rats

    Psychopharmacology (Berlin)

    (1999)
  • FM Behm et al.

    Reducing craving for cigarettes while decreasing smoking intake using capsaicin-enhanced low tar cigarettes

    Exp Clin Psychopharmacol

    (1994)
  • N Benowitz

    Nicotine replacement therapy: what has been accomplished—can we do better?

    Drugs

    (1993)
  • NL Benowitz

    Pharmacology of nicotine: addiction and therapeutics

    Annu Rev Pharmacol Toxicol

    (1996)
  • NL Benowitz et al.

    Smokers of low-yield cigarettes do not consume less nicotine

    N Engl J Med

    (1983)
  • NL Benowitz et al.

    Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine

    J Pharmacol Exp Ther

    (1998)
  • ME Benwell et al.

    Evidence that tobacco smoking increases the density of (−)-[3H]nicotine binding sites in human brain

    J Neurochem

    (1988)
  • MA Bozarth et al.

    Intravenous nicotine self-administration in laboratory animals: chasing the enigma

    Soc Neurosci Abstr

    (1996)
  • LH Brauer et al.

    Individual differences in smoking reward from de-nicotinized cigarette

    Nicotine Tob Res

    (2001)
  • CR Breese et al.

    Effect of smoking history on [3H]nicotine binding in human postmortem brain

    J Pharmacol Exp Ther

    (1997)
  • AR Caggiula et al.

    The role of environmental cues in the acquisition, extinction and reinstatement of nicotine self-administration

    Soc Neurosci Abstr

    (2000)
  • ME Carroll et al.

    Cocaine-base smoking in rhesus monkeys: reinforcing and physiological effects

    Psychopharmacology (Berlin)

    (1990)
  • JP Changeux et al.

    Acetylcholine receptor: an allosteric protein

    Science

    (1984)
  • C Chiamulera et al.

    Nicotine reinstatement of nicotine self-administration after long-term extinction

    Psychopharmacology (Berlin)

    (1996)
  • AR Childress et al.

    Classically conditioned factors in drug dependence

  • AR Childress et al.

    Limbic activation during cue-induced cocaine craving

    Am J Psychiatry

    (1999)
  • W Corrigall

    A rodent model for nicotine self-administration

  • WA Corrigall

    Nicotine self-administration in animals as a dependence model

    Nicotine Tob Res

    (1999)
  • WA Corrigall et al.

    Nicotine maintains robust self-administration in rats on a limited-access schedule

    Psychopharmacology (Berlin)

    (1989)
  • Cited by (0)

    View full text